ClinicalTrials.govpublic full text
Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients
myeloma, relapsed/refractory myeloma patients, progression free survival, overall survival, dasatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810571
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.